A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsy

Mol Genet Metab. 2026 Mar 3;148(2):109871. doi: 10.1016/j.ymgme.2026.109871. Online ahead of print.
No abstract available

Keywords: Congenital disorders of glycosylation; Defects of glycosylphosphatidylinositol (GPI) anchor synthesis; Developmental and epileptic encephalopathy; Myo-inositol.